Antibiotic Production: Streptomyces lincolnensis produces lincomycin, a lincosamide antibiotic. Lincomycin is effective against a wide range of Gram-positive bacteria, including staphylococci, streptococci, and anaerobic bacteria. It is used clinically to treat various infections, including skin and soft tissue infections, respiratory tract infections, and infections caused by anaerobic bacteria.
Clinical Applications: Lincomycin, produced by Streptomyces lincolnensis, has been used clinically for many years to treat bacterial infections in humans and animals. However, its use is now more limited due to the availability of other antibiotics and concerns about antibiotic resistance and side effects.
Antibiotic Resistance Studies: Streptomyces lincolnensis and its antibiotic, lincomycin, have been studied in the context of antibiotic resistance. Understanding the mechanisms of action and resistance to lincomycin can provide insights into combating antibiotic resistance in bacteria.
Biotechnological Applications: Lincomycin and its derivatives may have various biotechnological applications beyond medicine. They may be used in agriculture as growth promoters for livestock or in industry for the production of semi-synthetic antibiotics.
Environmental Health: Streptomyces lincolnensis, like other Streptomyces species, plays roles in soil ecology and nutrient cycling, which indirectly impact human health through ecosystem services such as soil fertility and environmental sustainability.
Other Sources for more information:
R2 | Slope | Tax Name | Parent Chart |
---|
R2 | Slope | Tax Name | Parent Chart |
---|---|---|---|
0.37866711616516113 | 0.5221154689788818 | Blautia obeum | Parent Taxa |
0.3724673092365265 | 0.4789027273654938 | Massilistercora timonensis | Parent Taxa |
0.36277762055397034 | 0.5358306765556335 | Blautia sp. SC05B48 | Parent Taxa |
0.318037748336792 | 0.6713635921478271 | Rothia kristinae | Parent Taxa |
0.31427136063575745 | 0.4770582318305969 | Dorea longicatena | Parent Taxa |
0.3046359419822693 | 0.5935442447662354 | Lactococcus lactis | Parent Taxa |
0.26919320225715637 | 0.624155580997467 | Lactococcus garvieae | Parent Taxa |
0.26759809255599976 | 0.4179517328739166 | Faecalitalea cylindroides | Parent Taxa |
0.26759183406829834 | 0.5069863200187683 | Bifidobacterium adolescentis | Parent Taxa |
0.2617317736148834 | 0.5868086218833923 | Ralstonia insidiosa | Parent Taxa |
0.2570902407169342 | 0.45672547817230225 | Coprococcus comes | Parent Taxa |
0.25686129927635193 | 0.6359958052635193 | Leuconostoc citreum | Parent Taxa |
0.2509133815765381 | 0.5522242188453674 | Bifidobacterium angulatum | Parent Taxa |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]